Quarterly report pursuant to Section 13 or 15(d)

Joint Venture and Options Transaction (Details)

v3.21.1
Joint Venture and Options Transaction (Details) - USD ($)
3 Months Ended 9 Months Ended
Mar. 01, 2020
Dec. 23, 2019
Jun. 24, 2019
Feb. 04, 2019
Jan. 29, 2019
Oct. 31, 2018
Feb. 28, 2021
Feb. 29, 2020
Feb. 28, 2021
Feb. 29, 2020
Joint Venture and Options Transaction (Details) [Line Items]                    
Financing Receivable, after Allowance for Credit Loss, Current           $ 5,000,000 $ 0   $ 0  
Note Receivable, Interest Rate, Stated Percentage           6.00%        
Interest Costs Capitalized                 212,601 $ 1,144,762
Proceeds from Collection of Notes Receivable                 1,544,291 325,000
Asset Impairment Charges             2,498,706 $ 0 2,498,706 0
Payments to Acquire Notes Receivable                 0 175,000
Joint Venture with CannAssist [Member]                    
Joint Venture and Options Transaction (Details) [Line Items]                    
Interest Income, Related Party             0 1,638 0 12,536
Proceeds from Collection of Notes Receivable   $ 342,567                
Financing Receivable, after Allowance for Credit Loss     $ 325,000              
Debt Instrument, Face Amount         $ 500,000          
Line of Credit Facility, Description         Any draws on the line of credit in excess of $150,000 will only be made in the sole discretion of the Company          
Debt Instrument, Interest Rate, Stated Percentage         8.00%          
Payments to Acquire Notes Receivable     $ 175,000 $ 150,000            
In Good Health [Member]                    
Joint Venture and Options Transaction (Details) [Line Items]                    
Business Combination, Consideration Transferred           $ 47,500,000        
Payments to Acquire Businesses, Gross           35,000,000        
Business Combination, Consideration Transferred, Liabilities Incurred           7,500,000        
Interest Income, Related Party             39,346 $ 74,795 149,972 $ 225,205
Interest Costs Capitalized $ 399,453                  
Proceeds from Collection of Notes Receivable             196,765   1,696,765  
Asset Impairment Charges                 2,498,706  
Interest Receivable             0   0  
Financing Receivable, after Allowance for Credit Loss             0   0  
Option Agreement, Brake-Up Fee           $ 2,500,000        
Interest Rate, Default           15.00%        
Debt Instrument, Interest Rate, Stated Percentage           6.00%        
Principal [Member] | Joint Venture with CannAssist [Member]                    
Joint Venture and Options Transaction (Details) [Line Items]                    
Proceeds from Collection of Notes Receivable   325,000                
Principal [Member] | In Good Health [Member]                    
Joint Venture and Options Transaction (Details) [Line Items]                    
Proceeds from Collection of Notes Receivable             158,340   1,544,291  
Asset Impairment Charges                 2,497,884  
Accrued Interest [Member] | Joint Venture with CannAssist [Member]                    
Joint Venture and Options Transaction (Details) [Line Items]                    
Proceeds from Collection of Notes Receivable   $ 17,567                
Accrued Interest [Member] | In Good Health [Member]                    
Joint Venture and Options Transaction (Details) [Line Items]                    
Proceeds from Collection of Notes Receivable             $ 38,424   152,473  
Asset Impairment Charges                 $ 822  
Option Agreement [Member] | In Good Health [Member]                    
Joint Venture and Options Transaction (Details) [Line Items]                    
Business Combination, Consideration Transferred           $ 47,500,000        
Payments to Acquire Businesses, Gross           35,000,000        
Business Combination, Consideration Transferred, Liabilities Incurred           7,500,000        
Business Combination, Consideration Transferred, Other           $ 2,500,000        
Debt Instrument, Term           5 years        
Option Agreement [Member] | Restricted Stock [Member] | In Good Health [Member]                    
Joint Venture and Options Transaction (Details) [Line Items]                    
Equity Issued in Business Combination, Fair Value Disclosure           $ 5,000,000